mrmarket.ai
Stock Overview

Becton Dickinson and Company (BDX)

NYSE · Healthcare · Medical Instruments & Supplies

Becton Dickinson and Company is a Healthcare company with a market capitalization of $48.80B, a trailing P/E ratio of 31.0, and a dividend yield of 2.06%.

Market Cap
$48.80B
P/E (TTM)
31.0
Forward P/E
13.3
Price/Sales
2.2
Price/Book
2.0
EV/EBITDA
13.2
Dividend Yield
2.06%
Beta
0.26
EPS (TTM)
$5.78
Profit Margin
5.3%
ROE
6.6%
Short % of Float
3.8%
Days to Cover
5.8
52W High
$184.21
52W Low
$137.03

5-Year Price History

Latest Annual Financials · FY ending September 30, 2025

Revenue
$21.84B
Gross Profit
$9.92B
Operating Income
$2.58B
Net Income
$1.68B
Free Cash Flow
$2.67B
Total Debt
$19.18B
Cash & Equivalents
$851.00M
Shareholder Equity
$25.39B

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q2 2026May 7, 2026$2.90$2.77+4.7%
Q1 2026February 9, 2026$2.91$2.80+3.9%
Q4 2025November 6, 2025$3.96$3.91+1.3%
Q3 2025August 7, 2025$3.68$3.42+7.6%
Q2 2025May 1, 2025$3.35$3.28+2.1%
Q1 2025February 5, 2025$3.43$2.99+14.7%

Short Interest

FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.

SettlementShares Short% of Shares OutDays to CoverChange
July 15, 202610,381,6153.70%5.8-7.6%
June 30, 202611,236,2464.00%2.9+54.4%
June 15, 20267,277,9322.59%3.6+1.0%
May 29, 20267,204,1432.57%2.4-14.4%
May 15, 20268,414,1233.00%2.3+31.9%
April 30, 20266,377,8602.24%2.1-11.6%
April 15, 20267,213,8052.53%2.9-24.0%
March 31, 20269,492,5573.33%4.2-17.2%

Other Medical Instruments & Supplies Stocks

ISRG
Intuitive Surgical Inc
$138.44B
MDLN
Medline Inc. Class A Common Stock
$49.88B
ALC
Alcon AG
$34.96B
RMD
ResMed Inc
$31.68B
WST
West Pharmaceutical Services Inc
$24.49B
COO
The Cooper Companies, Inc
$14.65B
SOLV
Solventum Corp.
$14.34B
BAX
Baxter International Inc
$13.86B
BDX vs ISRGBDX vs MDLNBDX vs ALC

Frequently Asked Questions

What is Becton Dickinson and Company's market cap?

As of August 13, 2026, Becton Dickinson and Company (BDX) has a market capitalization of $48.80B.

What is Becton Dickinson and Company's P/E ratio?

Becton Dickinson and Company trades at a trailing price-to-earnings (P/E) ratio of 31.0. Its forward P/E is 13.3.

Does Becton Dickinson and Company pay a dividend?

Yes — Becton Dickinson and Company pays a dividend yielding 2.06%, an annual payout of $1.04 per share.

What sector is BDX in?

Becton Dickinson and Company is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.

What is Becton Dickinson and Company's short interest?

As of the July 15, 2026 FINRA settlement, 10,381,615 BDX shares were sold short, or 3.70% of shares outstanding. Days to cover: 5.8. FINRA publishes short interest twice a month, about nine business days after each settlement date.

What was Becton Dickinson and Company's revenue?

In its latest reported fiscal year (ending September 30, 2025), Becton Dickinson and Company reported revenue of $21.84B and net income of $1.68B.

Ask your own questions about BDX

Try mrmarket.ai free

Data as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.